Shares of Encompass Health Corporation (EHC) have gained 30% in the past year compared with the industry's 15.6% growth. The Medical sector and the S&P 500 composite index rose 5.4% and 26.5%, respectively, in the same time frame. With a market capitalization of $8.5 billion, the average volume of shares traded in the last three months was 0.7 million. The leading rehabilitation hospital operator, presently carrying a Zacks Rank #2 (Buy), boasts an impressive track record of beating estimates in each of the ...

Company Overview - Encompass Health Corporation is a provider of integrated healthcare services, operating a network of 162 inpatient rehabilitation hospitals across 37 states and Puerto Rico, delivering high-quality, cost-effective care [12] - The company focuses on facility-based patient care and is positioned to benefit from coordinated care and integrated delivery payment models [12] Investment Potential - Encompass Health is identified as a top pick for growth investors, with a Growth Style Score of A, forecasting a year-over-year earnings growth of 12.6% for the current fiscal year [13] - The company holds a Zacks Rank of 2 (Buy) and a VGM Score of A, indicating strong potential for investment [23] Earnings Estimates - In the last 60 days, eight analysts have revised their earnings estimates upwards, with the Zacks Consensus Estimate increasing by $0.14 to $4.10 per share for fiscal 2024 [24] - Encompass Health has an average earnings surprise of 18.7%, suggesting a strong performance relative to expectations [24]

Encompass Health Corporation (EHC) recently opened the Rehabilitation Hospital of Atlanta at 1968 Peachtree Road NW. This new 40-bed inpatient rehabilitation hospital is a joint venture (JV) between Encompass Health and Piedmont, the largest healthcare system in the state of Georgia. The new hospital in Atlanta, GA, will help patients recover from amputations, brain injuries, complex orthopedic conditions, spinal cord injuries and strokes and regain function. Patients will receive at least three hours of in ...

It has been about a month since the last earnings report for Encompass Health (EHC) . Shares have added about 2.2% in that time frame, underperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is Encompass Health due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers. Encompass Health Q1 Earnings Beat, ...

The hospital is a joint venture between Piedmont and Encompass Health. BIRMINGHAM, Ala., and ATLANTA, May 23, 2024 /PRNewswire/ -- Piedmont, the largest healthcare system in the state of Georgia, and Encompass Health (NYSE: EHC), the nation's largest owner and operator of inpatient rehabilitation hospitals, announce the opening of Rehabilitation Hospital of Atlanta, a 40-bed inpatient rehabilitation hospital located at 1968 Peachtree Road NW, building 2 on the 6th floor. The hospital provides essential reha ...

Core Viewpoint - Encompass Health Corporation has opened a new 40-bed inpatient rehabilitation hospital in partnership with BJC HealthCare, enhancing its service capacity and market presence in the rehabilitation sector [1][2]. Company Expansion - The new hospital in Ballwin, MO, is part of a joint venture with BJC HealthCare, which now includes three hospitals, aimed at helping patients recover from various conditions [2]. - Encompass Health currently operates 162 hospitals across 37 states and Puerto Rico, with plans to add six new facilities and 280 beds in 2024 [3]. - Over the 2023-2027 period, the company aims to add 6-10 new facilities and increase bed capacity by 80-120 annually, targeting a compound annual growth rate (CAGR) of 6-8% in patient discharges [4]. Financial Performance - The growth initiatives are expected to enhance market share and financial returns, with a reported 2.8% year-over-year increase in net patient revenue per discharge in Q1 2024 [5]. - Encompass Health's shares have increased by 38.4% over the past year, outperforming the industry growth of 23.3% [6]. Market Position - Encompass Health holds a Zacks Rank 2 (Buy), indicating a favorable investment outlook, alongside other top-ranked companies in the medical sector [7].

The hospital is a joint venture between BJC HealthCare and Encompass Health. BIRMINGHAM, Ala. and BALLWIN, Mo., May 21, 2024 /PRNewswire/ -- BJC HealthCare, one of the largest nonprofit health care organizations in the United States, and Encompass Health (NYSE: EHC), the nation's largest owner and operator of inpatient rehabilitation hospitals, announce the opening of The Rehabilitation Institute of St. Louis – West County, a 40-bed inpatient rehabilitation hospital located at 998 Woods Mill Road. The hospi ...

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers. We also note that EHC holds a PEG ratio of 1.28. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into ...

Encompass Health Corporation (EHC) is aided by growing patient volumes, a sound business outlook for 2024, an expanding healthcare portfolio and a notable financial position. Top Zacks Rank & Upbeat Price Performance Encompass Health currently carries a Zacks Rank #2 (Buy). The EHC stock has gained 43.1% in the past year compared with the industry's 24.3% growth. The Zacks Medical sector has rallied 4.6% and the S&P 500 composite has risen 27.6% in the same time frame. Image Source: Zacks Investment Researc ...

Have you been paying attention to shares of Encompass Health (EHC) ? Shares have been on the move with the stock up 7.5% over the past month. The stock hit a new 52-week high of $86.72 in the previous session. Encompass Health has gained 29.7% since the start of the year compared to the 3.9% move for the Zacks Medical sector and the 9.6% return for the Zacks Medical - Outpatient and Home Healthcare industry.What's Driving the Outperformance?The stock has a great record of positive earnings surprises, as it ...